Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $12.38 billion. The enterprise value is $11.91 billion.
| Market Cap | 12.38B |
| Enterprise Value | 11.91B |
Important Dates
The last earnings date was Monday, April 22, 2024, after market close.
| Earnings Date | Apr 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 30.98 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Shares Outstanding | 30.98M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 17.84% |
| Owned by Institutions (%) | 85.29% |
| Float | 25.37M |
Valuation Ratios
The trailing PE ratio is 40.09 and the forward PE ratio is 34.79. MEDP's PEG ratio is 2.68.
| PE Ratio | 40.09 |
| Forward PE | 34.79 |
| PS Ratio | 6.21 |
| Forward PS | 5.28 |
| PB Ratio | 18.15 |
| P/FCF Ratio | 25.74 |
| PEG Ratio | 2.68 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.36, with an EV/FCF ratio of 25.17.
| EV / Earnings | 38.13 |
| EV / Sales | 6.07 |
| EV / EBITDA | 29.36 |
| EV / EBIT | 33.29 |
| EV / FCF | 25.17 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.20.
| Current Ratio | 0.78 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.29 |
| Interest Coverage | -79.67 |
Financial Efficiency
Return on equity (ROE) is 59.70% and return on invested capital (ROIC) is 37.86%.
| Return on Equity (ROE) | 59.70% |
| Return on Assets (ROA) | 19.70% |
| Return on Capital (ROIC) | 37.86% |
| Revenue Per Employee | $332,680 |
| Profits Per Employee | $52,967 |
| Employee Count | 5,900 |
| Asset Turnover | 1.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $49.93 million in taxes.
| Income Tax | 49.93M |
| Effective Tax Rate | 13.78% |
Stock Price Statistics
The stock price has increased by +90.89% in the last 52 weeks. The beta is 1.40, so MEDP's price volatility has been higher than the market average.
| Beta (1Y) | 1.40 |
| 52-Week Price Change | +90.89% |
| 50-Day Moving Average | 396.35 |
| 200-Day Moving Average | 315.37 |
| Relative Strength Index (RSI) | 52.92 |
| Average Volume (30 Days) | 248,291 |
Short Selling Information
The latest short interest is 942,773, so 3.04% of the outstanding shares have been sold short.
| Short Interest | 942,773 |
| Short Previous Month | 984,453 |
| Short % of Shares Out | 3.04% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 3.81 |
Income Statement
In the last 12 months, MEDP had revenue of $1.96 billion and earned $312.51 million in profits. Earnings per share was $9.81.
| Revenue | 1.96B |
| Gross Profit | 549.46M |
| Operating Income | 354.69M |
| Pretax Income | 362.43M |
| Net Income | 312.51M |
| EBITDA | 405.89M |
| EBIT | 357.94M |
| Earnings Per Share (EPS) | $9.81 |
Balance Sheet
The company has $407.01 million in cash and $136.16 million in debt, giving a net cash position of $270.85 million or $8.74 per share.
| Cash & Cash Equivalents | 407.01M |
| Total Debt | 136.16M |
| Net Cash | 270.85M |
| Net Cash Per Share | $8.74 |
| Equity / Book Value | 671.54M |
| Book Value Per Share | 21.67 |
| Working Capital | -211.74M |
Cash Flow
In the last 12 months, operating cash flow was $505.98 million and capital expenditures -$32.63 million, giving a free cash flow of $473.34 million.
| Operating Cash Flow | 505.98M |
| Capital Expenditures | -32.63M |
| Free Cash Flow | 473.34M |
| FCF Per Share | $15.35 |
Margins
Gross margin is 27.99%, with operating and profit margins of 18.07% and 15.92%.
| Gross Margin | 27.99% |
| Operating Margin | 18.07% |
| Pretax Margin | 18.47% |
| Profit Margin | 15.92% |
| EBITDA Margin | 20.68% |
| EBIT Margin | 18.24% |
| FCF Margin | 24.12% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.48% |
| Shareholder Yield | 0.48% |
| Earnings Yield | 2.56% |
| FCF Yield | 3.88% |
Analyst Forecast
The average price target for MEDP is $448.60, which is 12.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $448.60 |
| Price Target Difference | 12.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 14.24% |
| EPS Growth Forecast (5Y) | 17.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 8.02 and a Piotroski F-Score of 8.
| Altman Z-Score | 8.02 |
| Piotroski F-Score | 8 |